GLOBAL ALLAN-HERNDON-DUDLEY SYNDROME TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Allan-Herndon-Dudley Syndrome Treatment Market, By Treatment Type (Gene Therapy, Hormone Therapy), By End User (Hospital, Specialty Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI6559
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Global Allan-Herndon-Dudley Syndrome Treatment Market Size and Trends

The global Allan-Herndon-Dudley syndrome (AHDS) (MCT8 deficiency) market size is expected to reach US$ 17.5 Mn by 2030, from US$ 12 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period.

Global Allan-Herndon-Dudley syndrome (AHDS) (MCT8 deficiency) Treatment Market - Trends

Shift towards targeted therapies: The shift towards targeted therapies is having a significant influence on the global Allan-Herndon-Dudley syndrome (AHDS) market. Traditionally, the treatment for AHDS primarily focused on managing the symptoms through hormone replacement therapy. However, with advancements in understanding the genetic cause of this rare condition, there is a growing focus on the development of targeted therapeutic approaches.

Figure 2. Global Allan-Herndon-Dudley syndrome (AHDS) (MCT8 deficiency) Treatment Market Share (%), By Treatment Type, 2023